Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (119483) 119483
Newsletter (7015) 7015
Newspaper Article (1122) 1122
Book Chapter (765) 765
Dissertation (208) 208
Conference Proceeding (154) 154
Magazine Article (146) 146
Book / eBook (50) 50
Publication (25) 25
Reference (22) 22
Government Document (15) 15
Book Review (14) 14
Trade Publication Article (10) 10
Transcript (9) 9
Web Resource (9) 9
Journal / eJournal (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (89070) 89070
life sciences & biomedicine (80672) 80672
diabetes (63079) 63079
humans (56612) 56612
male (55994) 55994
animals (47393) 47393
female (37691) 37691
diabetes mellitus (31675) 31675
biological and medical sciences (27776) 27776
endocrinology & metabolism (26136) 26136
medical sciences (25996) 25996
type 2 diabetes (24572) 24572
rats (24550) 24550
middle aged (24416) 24416
adult (19797) 19797
glucose (19501) 19501
research (19125) 19125
endocrinopathies (18632) 18632
medical research (18483) 18483
risk factors (18332) 18332
endocrine pancreas. apud cells (18189) 18189
insulin (17902) 17902
diabetes. impaired glucose tolerance (17615) 17615
medicine, experimental (16484) 16484
aged (15988) 15988
mice (15316) 15316
blood glucose - metabolism (15284) 15284
insulin resistance (15123) 15123
analysis (13972) 13972
etiopathogenesis. screening. investigations. target tissue resistance (12048) 12048
medicine, research & experimental (12048) 12048
research & experimental medicine (11977) 11977
obesity (11639) 11639
medicine (11585) 11585
health aspects (11368) 11368
medicine & public health (11247) 11247
rodents (11222) 11222
internal medicine (10857) 10857
research article (10737) 10737
care and treatment (10720) 10720
diabetes mellitus, experimental - metabolism (10063) 10063
physiological aspects (9802) 9802
studies (9610) 9610
metabolism (9550) 9550
hypertension (9472) 9472
metabolic diseases (9324) 9324
hyperglycemia (9257) 9257
proteins (8996) 8996
pharmacology & pharmacy (8613) 8613
abridged index medicus (8260) 8260
inflammation (8044) 8044
oxidative stress (7984) 7984
dextrose (7958) 7958
streptozocin (7939) 7939
insulin - blood (7933) 7933
rats, wistar (7925) 7925
cardiovascular disease (7871) 7871
science & technology - other topics (7805) 7805
diabetes mellitus, experimental - drug therapy (7673) 7673
multidisciplinary sciences (7543) 7543
blood glucose - analysis (7511) 7511
diabetes mellitus, type 2 - blood (7493) 7493
diabetes therapy (7439) 7439
type 1 diabetes (7423) 7423
diabetics (7207) 7207
gene expression (7070) 7070
blood pressure (6915) 6915
cell biology (6575) 6575
body mass index (6538) 6538
diabetes mellitus, type 2 - drug therapy (6507) 6507
rats, sprague-dawley (6497) 6497
physiology (6462) 6462
science (6355) 6355
patients (6275) 6275
human physiology (6179) 6179
glucose metabolism (6120) 6120
diabetes mellitus, experimental - physiopathology (6102) 6102
hypoglycemic agents - therapeutic use (6091) 6091
cardiovascular diseases (6013) 6013
biochemistry & molecular biology (6007) 6007
body weight (5985) 5985
diabetes mellitus, experimental - blood (5982) 5982
cardiovascular system & cardiology (5944) 5944
insulin - metabolism (5845) 5845
atherosclerosis (5836) 5836
diabetes mellitus, type 2 - metabolism (5824) 5824
diabetes mellitus, type 2 - complications (5800) 5800
blood sugar (5776) 5776
mortality (5768) 5768
cholesterol (5675) 5675
time factors (5635) 5635
lipids (5450) 5450
disease models, animal (5434) 5434
diet (5294) 5294
mice, inbred c57bl (5201) 5201
development and progression (5140) 5140
diabetes mellitus, experimental - pathology (5044) 5044
metabolic disorders (5028) 5028
adolescent (4973) 4973
endocrinology (4973) 4973
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (127477) 127477
Japanese (796) 796
Chinese (543) 543
Portuguese (530) 530
Russian (456) 456
German (313) 313
Spanish (230) 230
French (226) 226
Persian (57) 57
Italian (54) 54
Polish (54) 54
Ukrainian (42) 42
Norwegian (34) 34
Turkish (29) 29
Korean (28) 28
Czech (18) 18
Indonesian (17) 17
Dutch (16) 16
Hungarian (16) 16
Slovak (16) 16
Romanian (11) 11
Bulgarian (7) 7
Croatian (6) 6
Swedish (6) 6
Serbian (5) 5
Danish (3) 3
Slovenian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Bosnian (1) 1
Breton (1) 1
Greek (1) 1
Macedonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Personalized Predictive Modeling in Type 1 Diabetes
by Georga, Eleni I and Fotiadis, Dimitrios I and Tigas, Stelios K
2017, ISBN 012804831X, 253
Biomathematics | Diabetes
eBook
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The use of animal models in diabetes research
by King, Aileen JF
British journal of pharmacology, ISSN 0007-1188, 06/2012, Volume 166, Issue 3, pp. 877 - 894
type 1 diabetes | animal models | type 2 diabetes | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Diabetes. Impaired glucose tolerance | Pharmacology. Drug treatments | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Obesity - complications | Diabetes Mellitus, Type 2 - genetics | Diabetes Mellitus, Experimental - genetics | Insulin Resistance | Diabetes Mellitus, Type 1 - genetics | Streptozocin - administration & dosage | Obesity - blood | Streptozocin - pharmacology | Insulin-Secreting Cells - immunology | Diabetes Mellitus, Experimental - immunology | Animals | Diabetes Mellitus, Experimental - etiology | Diabetes Mellitus, Type 1 - etiology | Insulin-Secreting Cells - virology | Diabetes Mellitus, Type 2 - immunology | Diabetes Mellitus, Type 1 - chemically induced | Dietary Fats - administration & dosage | Diabetes Mellitus, Type 2 - etiology | Diabetes Mellitus, Experimental - chemically induced | Diabetes Mellitus, Type 1 - immunology | Diabetes Mellitus, Type 2 - chemically induced | Insulin-Secreting Cells - pathology | Blood Glucose - metabolism | Index Medicus | Reviews
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
by Niewczas, Monika A and Pavkov, Meda E and Skupien, Jan and Smiles, Adam and Md Dom, Zaipul I and Wilson, Jonathan M and Park, Jihwan and Nair, Viji and Schlafly, Andrew and Saulnier, Pierre-Jean and Satake, Eiichiro and Simeone, Christopher A and Shah, Hetal and Qiu, Chengxiang and Looker, Helen C and Fiorina, Paolo and Ware, Carl F and Sun, Jennifer K and Doria, Alessandro and Kretzler, Matthias and Susztak, Katalin and Duffin, Kevin L and Nelson, Robert G and Krolewski, Andrzej S
Nature medicine, ISSN 1078-8956, 05/2019, Volume 25, Issue 5, pp. 805 - 813
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Prognosis | Prospective Studies | Diabetic Nephropathies - etiology | Diabetes Mellitus, Type 2 - genetics | Humans | Middle Aged | Male | Diabetes Mellitus, Type 1 - complications | Diabetic Nephropathies - blood | Blood Proteins - metabolism | Blood Proteins - genetics | Receptors, Tumor Necrosis Factor - blood | Adult | Female | Diabetes Mellitus, Type 2 - complications | Receptors, Tumor Necrosis Factor - genetics | Risk Factors | Inflammation Mediators - blood | Diabetes Mellitus, Type 1 - genetics | Diabetic Nephropathies - genetics | Biomarkers - blood | Disease Progression | Kidney Failure, Chronic - genetics | Diabetes Mellitus, Type 2 - blood | Kidney Failure, Chronic - blood | Diabetes Mellitus, Type 1 - blood | Proteomics | Aged | Cohort Studies | Kidney Failure, Chronic - etiology | Complications and side effects | Chronic kidney failure | Tumor necrosis factor | Cytokine receptors | Development and progression | Diabetes | Health aspects | Risk factors | End-stage renal disease | Kidneys | Therapeutic applications | Medical treatment | Diabetes mellitus | Health risks | Risk | Diabetes mellitus (insulin dependent) | Inflammation | Proteins | Developmental stages | Biomarkers | Kidney diseases | Diabetes mellitus (non-insulin dependent) | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Experimental Diabetes Mellitus in Different Animal Models
by Al-awar, Amin and Kupai, Krisztina and Veszelka, Médea and Szűcs, Gergő and Attieh, Zouhair and Murlasits, Zsolt and Török, Szilvia and Pósa, Anikó and Varga, Csaba
Journal of diabetes research, ISSN 2314-6745, 8/2016, Volume 2016, pp. 9051426 - 12
Animals | Diabetes Mellitus, Type 2 - physiopathology | Diabetes Mellitus, Type 1 - physiopathology | Diabetes Mellitus, Type 1 - metabolism | Rats | Mice | Diabetes Mellitus, Type 2 - metabolism | Blood Glucose - metabolism | Diabetes Mellitus, Experimental - metabolism | Diabetes Mellitus, Experimental - physiopathology | Disease Models, Animal | Obesity | Insulin resistance | Mutation | Rodents | Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance
by Dai, Bing and Wu, Qinxuan and Zeng, Chengxi and Zhang, Jiani and Cao, Luting and Xiao, Zizeng and Yang, Menglin
Journal of ethnopharmacology, ISSN 0378-8741, 11/2016, Volume 192, pp. 382 - 389
PI3K/Akt signaling pathway | Liuwei Dihuang decoction | Type 2 diabetes mellitus | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Integrative & Complementary Medicine | Plant Sciences | Science & Technology | Diabetes Mellitus, Experimental - drug therapy | Liver - pathology | Phosphorylation | Liver - enzymology | Diabetes Mellitus, Experimental - enzymology | Streptozocin | Drugs, Chinese Herbal - pharmacology | Male | Insulin Receptor Substrate Proteins - metabolism | Insulin - blood | RNA, Messenger - metabolism | Proto-Oncogene Proteins c-akt - genetics | Diabetes Mellitus, Experimental - blood | Liver - drug effects | Time Factors | Diabetes Mellitus, Experimental - chemically induced | Insulin Receptor Substrate Proteins - genetics | Proto-Oncogene Proteins c-akt - metabolism | Phosphatidylinositol 3-Kinase - metabolism | Pancreas - enzymology | RNA, Messenger - genetics | Diabetes Mellitus, Type 2 - enzymology | Insulin Resistance | Pancreas - drug effects | Pancreas - pathology | Biomarkers - blood | Rats, Sprague-Dawley | Hypoglycemic Agents - pharmacology | Blood Glucose - drug effects | Gene Expression Regulation, Enzymologic | Diabetes Mellitus, Type 2 - blood | Animals | Phosphatidylinositol 3-Kinase - genetics | Signal Transduction - drug effects | Diabetes Mellitus, Type 2 - chemically induced | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Insulin resistance | Medicine, Chinese | Liver | Physiological aspects | Blood sugar | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism
by Liang, Guang and Song, Lintao and Chen, Zilu and Qian, Yuanyuan and Xie, Junjun and Zhao, Longwei and Lin, Qian and Zhu, Guanghui and Tan, Yi and Li, Xiaokun and Mohammadi, Moosa and Huang, Zhifeng
Kidney international, ISSN 0085-2538, 01/2018, Volume 93, Issue 1, pp. 95 - 109
cytokines | fibrosis | inflammation | mesangial cells | diabetic nephropathy | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Diabetes Mellitus, Experimental - drug therapy | Kidney - pathology | Rats, Wistar | Diabetic Nephropathies - etiology | Humans | JNK Mitogen-Activated Protein Kinases - metabolism | Male | NF-kappa B - metabolism | Diabetes Mellitus, Type 1 - complications | Diabetic Nephropathies - blood | Diabetes Mellitus, Experimental - blood | Kidney - metabolism | Inflammation Mediators - metabolism | Diabetes Mellitus, Experimental - complications | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Cell Line | Diabetic Nephropathies - pathology | Kidney - drug effects | Cytokines - metabolism | Anti-Inflammatory Agents - pharmacology | Mice, Inbred C57BL | Recombinant Proteins - pharmacology | Diabetes Mellitus, Type 1 - drug therapy | Blood Glucose - drug effects | Fibroblast Growth Factor 1 - blood | Diabetes Mellitus, Type 2 - blood | Macrophages - metabolism | Animals | Signal Transduction - drug effects | Diabetes Mellitus, Type 1 - blood | Fibroblast Growth Factor 1 - pharmacology | Macrophages - drug effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Atorvastatin prevents type 2 diabetes mellitus—An experimental study
by Madhu, Sri Venkata and Aslam, Mohammad and Galav, Vikas and Bhattacharya, Swapan Kumar and Jafri, Aiman Abbas
European journal of pharmacology, ISSN 0014-2999, 04/2014, Volume 728, Issue 1, pp. 135 - 140
Type 2 diabetes | Atorvastatin | Insulin resistance | Hypertriglyceridemia | Impaired glucose tolerance | Glucose area under the curve | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Glucose Tolerance Test | Blood Glucose - analysis | Rats, Wistar | Cholesterol - blood | Heptanoic Acids - therapeutic use | Diabetes Mellitus, Type 2 - prevention & control | Insulin Resistance | Body Weight - drug effects | Rats | Male | Diabetes Mellitus, Type 2 - metabolism | Insulin - blood | Atorvastatin Calcium | Animals | Diabetes Mellitus, Experimental - prevention & control | Pyrroles - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipid Metabolism - drug effects | Triglycerides - blood | Heptanoic Acids - administration & dosage | Diabetes Mellitus, Experimental - metabolism | Pyrroles - therapeutic use | Prevention | Glucose metabolism | Streptozocin | Analysis | Body weight | Physiological aspects | Glucose | Dextrose | Antilipemic agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights